Phase II trial of extended-dosing temozolomide in patients with melanoma
Year: 2006
Type: conference-abstract
Source: Journal of Clinical Oncology
Institution: Memorial Sloan Kettering Cancer Center
Language: English
Subfield: Oncology
Field: Medicine
Domain: Health Sciences
Open Access status: closed
OpenAlex ID: W2271881091
